Russell F. DeVore
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 5%
- Epidemiology top 10%
- Co-authors
- David H. JohnsonJacques GaudreaultDavid M. JablonsEric HolmgrenJohn NemunaitisWilliam NovotnyRoy S. HerbstLouis Fehrenbacher
- Topics
- Lung Cancer Research Studies (15 papers)Cancer therapeutics and mechanisms (14 papers)Lung Cancer Treatments and Mutations (9 papers)
- Partner nations
- United StatesTaiwanCanada
In The Last Decade
Russell F. DeVore
28 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 2.4k
- Molecular Biology 1.3k
- Cancer Research 460
- Epidemiology 374
Countries citing papers authored by Russell F. DeVore
This map shows the geographic impact of Russell F. DeVore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell F. DeVore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell F. DeVore more than expected).
Fields of papers citing papers by Russell F. DeVore
This network shows the impact of papers produced by Russell F. DeVore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell F. DeVore. The network helps show where Russell F. DeVore may publish in the future.
Co-authorship network of co-authors of Russell F. DeVore
This figure shows the co-authorship network connecting the top 25 collaborators of Russell F. DeVore. A scholar is included among the top collaborators of Russell F. DeVore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell F. DeVore. Russell F. DeVore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancerbreakdown → | 1516 |
| 3 | 97 | |
| 4 | 91 | |
| 5 | 16 | |
| 6 | 81 | |
| 7 | Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimensbreakdown → | 1124 |
| 8 | 125 | |
| 9 | 10 | |
| 10 | 162 | |
| 11 | 13 | |
| 12 | 0 | |
| 13 | Phase I study of the antineovascularization drug CM101. | 35 |
| 14 | 6 | |
| 15 | 21 | |
| 16 | Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial. | 5 |
| 17 | 9 | |
| 18 | 28 | |
| 19 | Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drugs etoposide and 4'-(9-acridinylamino)methane-sulfon-m-anisidide. | 84 |
| 20 | 78 |
About Russell F. DeVore
Russell F. DeVore is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 29 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (15 papers), Cancer therapeutics and mechanisms (14 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Oncology (2.8k citations), Pulmonary and Respiratory Medicine (2.4k citations) and Cancer Research (460 citations). Russell F. DeVore has collaborated with scholars based in United States, Taiwan and Canada. Frequent co-authors include David H. Johnson, Jacques Gaudreault, David M. Jablons, Eric Holmgren, John Nemunaitis, William Novotny, Roy S. Herbst, Louis Fehrenbacher, Corey J. Langer and Fairooz F. Kabbinavar. Their work appears in journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.